Medigen 結果共12筆

The Kuomintang (KMT) responds to proposals from the Taiwan People’s Party (TPP) regarding future operations in the new legislature, promising to respect the opinions of the Legislative Yuan party groups. As the majority in parliament, the KMT pledges to provide vigorous oversight and advance the issues agreed upon in the cross-party meeting with the TPP on October 30th last year. Agreed matters include peace and stability across the Taiwan Strait, resumption of cross-strait dialogue, environmental sustainability, national security, public health, and strengthening the legislature’s function under the existing constitutional system. The KMT emphasizes its unchanged vision for Taiwan’s future development. Additionally, they plan to scrutinize issues such as the controversy over the purchase contracts of the Medigen COVID-19 vaccine by the ruling Democratic Progressive Party (DPP) government. The KMT welcomes those with similar political ideals to join in preventing authoritarian one-party rule and ensuring democracy aligns with the public’s wishes.

KMT presidential candidate Hou Yu-ih proposes a third wave of democratic reforms and a coalition government, inviting individuals outside of the KMT such as TPP candidate Ko Wen-je and Foxconn founder Terry Gou. He criticizes DPP candidate Lai Ching-te for lack of transparency regarding the Medigen Covid-19 vaccine and accuses the DPP of improper governance and corruption. The campaign rally in Tainan attracted 50,000 supporters with prominent KMT officials in attendance.

Premier Chen Chien-jen discusses the pricing process and confidentiality agreements surrounding Medigen vaccines, stating that negotiations with the Centers for Disease Control (CDC) are ongoing. As a publicly listed company, any decisions about publicizing the government contract require shareholders’ approval. Chen emphasizes the government’s belief in vaccination as the best measure against the pandemic. Medigen had positive results from phase one trials and clinical experiments, leading to phase two development. The World Health Organization (WHO) conducted unity trials with four other countries after being unable to proceed with phase three trials due to Taiwan’s low COVID-19 case statistics. Chen disputes rumors about a 30-year embargo on clinical results, calling it fake news and clarifying that all official documents have a preservation period. He also refutes accusations that over a thousand Medigen shareholders are members of the Democratic Progressive Party (DPP), calling them ＂imaginary numerical figures.＂ Chen hopes to disclose the information as soon as possible to maintain public trust, but it can only happen after negotiations and respecting existing confidentiality agreements.

Vice Presidential candidate Hsiao Bi-khim of the Democratic Progressive Party (DPP) vows to review and reflect on corruption allegations within the DPP government. This comes after her opponent, Kuomintang’s (KMT) Jaw Shaw-kong, accused the DPP of corruption during a policy presentation. Jaw raised concerns about the DPP obstructing Terry Gou’s acquisition of Pfizer-BioNTech vaccines and questioned the increase in the market value of Medigen Vaccine Biologics Corp. He advocated for the reinstatement of the Special Investigation Division to tackle corruption. Hsiao acknowledges mistakes within the party and emphasizes the need for self-review. She highlights the DPP’s commitment to reform and progressive policies, citing examples of marriage equality and energy transformation. Hsiao compares the government to a team in an international competition, emphasizing the importance of guidance and support for a unified nation.

The Ministry of Economic Affairs (MOEA) demanded an apology from Taiwan People’s Party (TPP) chairman Ko Wen-je for his corruption allegations against the government in producing face masks. The MOEA refuted Ko’s claims, stating the lack of evidence and emphasizing the need for public servants to ensure mask supply during the pandemic. Ko made the accusations during a campaign event, implicating the ruling Democratic Progressive Party (DPP) in corruption cases involving masks, the Medigen COVID-19 vaccine, and egg imports. The MOEA referred to a previous incident where former Minister of the Interior Lee Hong-yuan apologized for baseless accusations and urged Ko to do the same.

Deputy Minister of Health and Welfare, Wang Pi-sheng, criticizes the ban of certain flu vaccine brands in schools, calling it a political move that exploits students. The government has approved a new flu vaccine from Medigen, but rumors of public resistance have led some regions to prohibit its use in schools. Wang argues that the government should help citizens make informed decisions based on scientific evidence.

Taichung Mayor Lu Shiow-yen emphasized transparency in flu vaccine information during the Municipal Administrative Meeting. The central government has purchased publicly-funded flu vaccines from four companies: Sanofi, Adimmune, TTY Biopharm, and Medigen. These vaccines will be available across all cities and counties.

The Taiwan FactCheck Center has clarified that MVC’s quadrivalent influenza vaccine is produced by the reputable South Korean pharmaceutical firm GC Biopharma, which has WHO qualification and is marketed in multiple countries. Additionally, the FactCheck Center noted that MVC’s method of vaccine production is not unprecedented, as other domestic manufacturers have also imported foreign vaccine stock solutions for local assembly.

On Wednesday (Sept .6), the Shihlin District Court ruled that Liu Tsang-wu, a member of the vaccine review committee under the Food and Drug Administration (FDA), was guilty of leaking confidential information about the Medigen vaccine.

The head of the Central Epidemic Command Center (CECC), Wang Pi-sheng, refuted claims on Tuesday (Nov. 1) that health authorities purchased Medigen vaccines above the market price. 

泰國政府宣布，承認我國國產高端疫苗（Medigen），這也是繼紐西蘭、帛琉、印尼、貝里斯之後，第五個認可高端疫苗的國家，目前澳洲仍在審查當中。

泰國政府10日宣布，將台灣國產的高端疫苗（Medigen）列入邊境管制的旅遊可入境或入境免隔離認可名單，成為第5個認可高端COVID-19疫苗的國家；高端表示，陸續有國家要資料進行審查，也感謝泰國的認可。